Annual Meeting opened with record attendance

This year’s meeting celebrates the anniversary of the largest annual European expert meeting on cancer immunotherapy.

The meeting features a diverse program, with poster sessions and an industry exhibition covering a wide range of topics in cancer immunotherapy research and development. Attendees will have the opportunity to interact with leading experts, share their insights, and discuss the latest scientific and clinical breakthroughs in cancer immunotherapy.

Prof. Christoph Huber, founding member of the CIMT Association, is excited about the high number of participants who came to Mainz this year. “The CIMT Annual Meeting has always been at the forefront of presenting the latest research and fostering collaboration between experts worldwide.” CIMT Board Chairwoman Prof. Özlem Türeci added, “This year’s program is a testament to the scientific community’s continued commitment to making significant progress in the development of cancer immunotherapies.”

Clemens Hoch, Minister of Science and Health of Rhineland-Palatinate, delivered the welcoming address at the opening of the meeting. The minister highlighted the crucial role of international scientific collaboration in the fight against cancer, as well as the region’s innovative strength in this field. “The CIMT Annual Meetings stand for scientific exchange at the highest level and the initiation as well as deepening of valuable collaboration in the field of cancer immunotherapy. The potential is great, which is also shown by the professional interest with more than 300 abstracts submitted. I am delighted that such an event is taking place in Mainz, a city that itself stands for innovation from Gutenberg to BioNTech and we have consistently promoted research in immunology and mRNA for more than 30 years, “said the Minister of Science and Health of Rhineland-Palatinate, Clemens Hoch, at the opening of the meeting.